MALCOLM JAN sold 41.9% of their position (325.00 shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $178.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/10/2026ACC: 0002028640-26-000007
-325.00
Net shares
Net seller
$178.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
650.00 acquired · 975.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+650.00
Price / share
—
Trade value
—
% of position
520.0%
7/9/2026
125.00→775.00
Common Stock
Direct
Shares
−325.00
Price / share
$550.59
Trade value
$178.94K
% of position
41.9%
7/10/2026
775.00→450.00
Total
Net shares
+325.00
Net value
-$178.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2026 | M · Option Exercise | +650.00 | — | — | 520.0% | 125.00 | 775.00 |
| Common Stock Direct | 7/10/2026 | S · Sale | −325.00 | $550.59 | $178.94K | 41.9% | 775.00 | 450.00 |
| Total | +325.00 | -$178.94K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
650.00 shares
Shares
−650.00
Strike price
0.00
Held after
0.00
Exercisable
—
7/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock650.00 shares | 7/9/2026 | M · Option Exercise | −650.00 | 0.00 | — | 0.00 |